Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMDGet Rating) in a research note issued to investors on Friday. The firm set a “sell” rating on the medical equipment provider’s stock.

Separately, Maxim Group lowered Aethlon Medical from a “buy” rating to a “hold” rating in a report on Tuesday, November 15th.

Aethlon Medical Trading Up 8.2 %

NASDAQ:AEMD opened at $0.44 on Friday. The firm has a market cap of $7.25 million, a PE ratio of -0.56 and a beta of 0.89. The stock has a fifty day moving average price of $0.57 and a 200 day moving average price of $0.95. Aethlon Medical has a 12-month low of $0.39 and a 12-month high of $2.73.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Natixis acquired a new stake in Aethlon Medical in the second quarter valued at $28,000. Buckingham Strategic Partners acquired a new stake in shares of Aethlon Medical during the third quarter worth about $29,000. Two Sigma Investments LP acquired a new stake in shares of Aethlon Medical during the third quarter worth about $32,000. Renaissance Technologies LLC acquired a new stake in shares of Aethlon Medical during the third quarter worth about $36,000. Finally, Citadel Advisors LLC acquired a new stake in shares of Aethlon Medical during the third quarter worth about $72,000. 5.94% of the stock is currently owned by hedge funds and other institutional investors.

Aethlon Medical Company Profile

(Get Rating)

Aethlon Medical, Inc, a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes.

Recommended Stories

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.